Co‐drug development of gallic acid and metformin targeting the pro‐inflammatory cytokines for the treatment of breast cancer

Journal article

Peer reviewed

Vikas Kumar, Kalicharan Sharma, Richa Sachan, Sultan Alhayyani, Fahd A. Al-abbasi, Richa Singh and Firoz Anwar

Journal of biochemical and molecular toxicology, Vol.37(4), pp.e23300-n/a

04/2023

PMID: 36703564

Metrics

1 Record Views

Title: Co‐drug development of gallic acid and metformin targeting the pro‐inflammatory cytokines for the treatment of breast cancer
Creators - without role: Vikas Kumar - Sam Higginbottom Institute of Agriculture
Kalicharan Sharma - Delhi Pharmaceutical Science and Research University
Richa Sachan - Sungkyunkwan University
Sultan Alhayyani - King Abdulaziz University
Fahd A. Al-abbasi - King Abdulaziz University
Richa Singh - Sam Higginbottom Institute of Agriculture
Firoz Anwar - King Abdulaziz University
Publication Details: Journal of biochemical and molecular toxicology, Vol.37(4), pp.e23300-n/a
Identifiers: 9934615208331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article